Search results for "INTERLEUKIN-2"

showing 10 items of 269 documents

Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen.

1993

The polyclonal stimulation of T cells by bacterial superantigens is involved in the pathogenesis of the toxic shock syndrome in certain staphylococcal and streptococcal infections. Here we describe the onset and kinetics of superantigen-induced cytokine production in situ in spleens of normal BALB/c mice monitored at the level of cytokine mRNA expression by in situ hybridization. Messenger RNAs for interleukin 2 (IL-2), interferon gamma, and tumor necrosis factors (TNF) alpha and beta were not expressed at detectable levels in spleens of unstimulated animals but became visible already 30 min after intraperitoneal application of 50 micrograms staphylococcal enterotoxin B. All mRNA levels sho…

Interleukin 2LipopolysaccharidesSalmonella typhimuriumStaphylococcus aureusInterferon type IITranscription Geneticmedicine.medical_treatmentT cellT-LymphocytesImmunologyGene ExpressionBiologyEnterotoxinsMiceAldesleukinGene expressionmedicineSuperantigenImmunology and AllergyAnimalsInterferon gammaRNA MessengerIn Situ HybridizationMice Inbred BALB CSuperantigensTumor Necrosis Factor-alphaMacrophagesArticlesMolecular biologyKineticsCytokinemedicine.anatomical_structureCytokinesInterleukin-2Spleenmedicine.drugThe Journal of experimental medicine
researchProduct

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.

2007

Abstract The increasing evidence that γδ T cells have potent antitumor activity suggests their value in immunotherapy, particularly in areas of unmet need such as metastatic carcinoma. To this end, we initiated a phase I clinical trial in metastatic hormone-refractory prostate cancer to examine the feasibility and consequences of using the γδ T-cell agonist zoledronate, either alone or in combination with low-dose interleukin 2 (IL-2), to activate peripheral blood γδ cells. Nine patients were enlisted to each arm. Neither treatment showed appreciable toxicity. Most patients were treated with zoledronate + IL-2, but conversely only two treated with zoledronate displayed a significant long-te…

Interleukin 2MaleCancer ResearchNeoplasms Hormone-Dependentmedicine.medical_treatmentT cellT-LymphocytesAntineoplastic AgentsLymphocyte ActivationZoledronic AcidArticleMetastatic carcinomaProstate cancerAntigenMedicineHumansAgedAged 80 and overSalvage TherapyBone Density Conservation AgentsDiphosphonatesDose-Response Relationship Drugbusiness.industryRemission InductionImidazolesProstatic NeoplasmsReceptors Antigen T-Cell gamma-deltaImmunotherapyMiddle Agedmedicine.diseaseVγ9Vδ2 T cellsZoledronateIL-2Hormone-refractory prostate cancerImmunotherapyCytokinemedicine.anatomical_structureTreatment OutcomeOncologyImmunologyFeasibility StudiesInterleukin-2Tumor necrosis factor alphaDrug Therapy CombinationImmunotherapybusinessmedicine.drug
researchProduct

Interleukin 4 suppresses primary interferon gamma response by T cells immunized in vivo and cultured in vitro with interleukin 2.

1996

This paper describes a novel primary in vivo/in vitro culture system which allows analysis of the effect of IL-4 added to culture 1 day after immunization on the production of IFN-gamma. Mice are immunized epicutaneously with picryl chloride (TNP) and draining lymph node cells were harvested 1 day later. These cells (1 day lymph node cells), when cultured in vitro for 3 days in the presence of IL-2, either continuously or as a pulse, give an IFN-gamma response on reexposure to antigen 3 days later. This production of IFN-gamma is both antigen-specific and genetically (MHC)-restricted and is due to both CD8+ and CD4+ T cells. However, if 1 day lymph node cells are cultured with both IL-2 and…

Interleukin 2MaleT-LymphocytesImmunologyMice Inbred StrainsPicryl ChlorideBiologyMajor histocompatibility complexBiochemistryPicryl chlorideMajor Histocompatibility Complexchemistry.chemical_compoundEpitopesInterferon-gammaMiceAntigenmedicineImmunology and AllergyAnimalsInterferon gammaMolecular BiologyLymph nodeInterleukin 4Cells CulturedHematologyMolecular biologyInterleukin-10Kineticsmedicine.anatomical_structurechemistryDepression ChemicalImmunologybiology.proteinInterleukin-2ImmunizationInterleukin-4Lymph NodesCD8medicine.drugCytokine
researchProduct

Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.

2015

Human group 1 ILCs consist of at least three phenotypically distinct subsets, including NK cells, CD127(+) ILC1, and intraepithelial CD103(+) ILC1. In inflamed intestinal tissues from Crohn's disease patients, numbers of CD127(+) ILC1 increased at the cost of ILC3. Here we found that differentiation of ILC3 to CD127(+) ILC1 is reversible in vitro and in vivo. CD127(+) ILC1 differentiated to ILC3 in the presence of interleukin-2 (IL-2), IL-23, and IL-1β dependent on the transcription factor RORγt, and this process was enhanced in the presence of retinoic acid. Furthermore, we observed in resection specimen from Crohn's disease patients a higher proportion of CD14(+) dendritic cells (DC), whi…

Interleukin 2Receptors Retinoic AcidCellular differentiationCD14ImmunologyInterleukin-1betaRetinoic acidLipopolysaccharide Receptorschemical and pharmacologic phenomenaTretinoinMice SCIDBiologyInterleukin-12 Subunit p35Interleukin-7 Receptor alpha Subunitchemistry.chemical_compoundMiceIntestinal mucosaCrohn DiseaseMice Inbred NODmedicineImmunology and AllergyAnimalsHumansRetinoid X Receptor gammaLymphocytesIntestinal MucosaInterleukin-7 receptorCells CulturedMice KnockoutRetinoic Acid Receptor alphaInnate lymphoid cellvirus diseaseshemic and immune systemsCell DifferentiationDendritic CellsNuclear Receptor Subfamily 1 Group F Member 3Molecular biologyKiller Cells NaturalMice Inbred C57BLInfectious DiseaseschemistryLymphocyte TransfusionImmunologyInterleukin 12Interleukin-23 Subunit p19Interleukin-2medicine.drugImmunity
researchProduct

Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-l…

2001

ABSTRACTWe investigated the rotavirus-specific lymphocyte responses induced by intranasal immunization of adult BALB/c mice with rotavirus 2/6 virus-like particles (2/6-VLPs) of the bovine RF strain, by assessing the profile of cytokines produced after in vitro restimulation and serum and fecal antibody responses. The cytokines produced by splenic cells were first evaluated. Intranasal immunization with 50 μg of 2/6-VLPs induced a high serum antibody response, including immunoglobulin G1 (IgG1) and IgG2a, a weak fecal antibody response, and a mixed Th1/Th2-like profile of cytokines characterized by gamma interferon and interleukin 10 (IL-10) production and very low levels of IL-2, IL-4, and…

Interleukin 2RotavirusCholera ToxinLymphocyteImmunologyBacterial ToxinsBiologymedicine.disease_causeMicrobiologyMicrobiology03 medical and health sciencesEnterotoxinsInterferon-gammaMiceImmune systemTh2 CellsAdjuvants ImmunologicVirologyChlorocebus aethiopsmedicineAnimalsInterferon gammaInterleukin 5Administration Intranasal030304 developmental biology[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology0303 health sciencesMice Inbred BALB C030306 microbiologyToxinEscherichia coli ProteinsCholera toxinVirionTh1 Cells3. Good healthVIROLOGIEmedicine.anatomical_structureImmunizationInsect Science[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyImmunologyPathogenesis and ImmunityCytokinesInterleukin-2FemaleImmunizationInterleukin-5medicine.drug
researchProduct

IL-2, IL-3, and IFN-gamma differently affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-p)

1993

Experimental animal and human in vivo studies have previously demonstrated the impact of exogenous administration of various cytokines on frequencies of circulating myeloid and LAK precursor cells. For the first time we investigated whether exogenous cytokines, in the absence of antigenic challenge, may also influence frequencies of circulating antigen-specific cytotoxic T-lymphocyte precursor cells. We further asked whether triggering of autoimmune pathways as has been reported for several cytokines can be confirmed on the cellular level by demonstration of induction of autoreactive CTL-p. Limiting dilution analysis was used to determine alloreactive CTL-p frequencies in 31 patients with n…

Interleukin 2Stem Cellsmedicine.medical_treatmentClone (cell biology)Autoimmunityhemic and immune systemschemical and pharmacologic phenomenaHematologyGeneral MedicineBiologyRecombinant ProteinsInterferon-gammaCTL*CytokineImmunologymedicineSystemic administrationHumansInterleukin-2Cytotoxic T cellInterleukin-3Interferon gammaT-Lymphocytes CytotoxicInterleukin 3medicine.drugAnnals of Hematology
researchProduct

Interleukin 2 Induction in Lyt 1 + 23 − T Cells from Listeria monocytogenes -Immune Mice

1982

Peritoneal exudate T lymphocytes from mice experimentally infected with the intracellular bacterium Listeria monocytogenes secreted high interleukin 2 activities after interaction with syngeneic normal macrophage presenting listerial antigen in vitro. L. monocytogenes -immune cells secreting IL 2 were radioresistant and bore the phenotype Thy 1 + Lyt 1 + 23 − .

Interleukin 2T-LymphocytesImmunologyBiologymedicine.disease_causeMicrobiologyMicrobiologyMiceImmune systemAntigenListeria monocytogenesRadioresistancemedicineAnimalsAntigens LyMacrophageListeriosisAntigens BacterialMacrophagesListeria monocytogenesPhenotypeIn vitroPhenotypeInfectious DiseasesAntigens SurfaceInterleukin-2Thy-1 AntigensParasitologymedicine.drugInfection and Immunity
researchProduct

Effect of isoprinosine on IL-2, IFN-γ and IL-4 production in vivo and in vitro

1991

The effects of an immunopotentiating drug, isoprinosine, on the splenocytes of BALB/c mice to produce cytokines were investigated. Isoprinosine enhanced IL-2 production, upregulating the expression of IL-2 receptor in vitro. It also significantly increased the IFN-gamma secretion and decreased the IL-4 production in vivo. The significance of these findings in terms of immune regulation is discussed.

Interleukin 2medicine.drug_classImmunologyIn Vitro TechniquesBiologyImmunostimulantInterferon-gammaMiceT-Lymphocyte SubsetsIn vivoInosine PranobexmedicineSplenocyteAnimalsInterferon gammaReceptorInterleukin 4PharmacologyMice Inbred BALB CIn vitroImmunologyInterleukin-2FemaleInterleukin-3Interleukin-4Spleenmedicine.drugInternational Journal of Immunopharmacology
researchProduct

Growth, interleukin-2 production, and responsiveness to IL-2 in T4- positive T Lymphocyte populations from malignant cutaneous T cell lymphoma (Sezar…

1984

Abstract Functional analysis and surface phenotyping using monoclonal antibodies have revealed that malignant T lymphocyte populations in the peripheral blood of patients with Sezary's syndrome resemble the T helper cell populations from normal individuals. In this article we have studied the effects of the immunosuppressive drug cyclosporine A (CsA) on growth, interleukin-2 (IL-2) production, and the induction of IL-2 responsiveness of peripheral blood monocytes (PBMs) from five patients with Sezary's syndrome in vitro, using the lectin phytohemagglutinin (PHA) and the phorbol ester phorbol myristate acetate (PMA) as stimuli. The following results were obtained: PHA-induced cell proliferat…

Interleukin 2medicine.medical_specialtyT cellImmunologyCyclosporinsBiologyLymphocyte ActivationBiochemistryCyclosporin aInternal medicinemedicineHumansSezary SyndromePhytohemagglutininsReceptorCell growthCutaneous T-cell lymphomaT-Lymphocytes Helper-InducerCell BiologyHematologyT helper cellT lymphocytemedicine.diseasePhenotypemedicine.anatomical_structureEndocrinologyInterleukin-2Tetradecanoylphorbol Acetatemedicine.drugBlood
researchProduct

Establishment of different T cell sublines using either interleukin 2 or interleukin 4 as growth factors

1990

Purified protein derivative reactive T cell lines were established under identical conditions with the exception that different lymphokines, namely interleukin (IL) 2 and IL 4 were employed as growth factors. IL 2 favored the development of T cell lines (LNC.2) which upon activation by concanavalin A (Con A) secreted predominantly lymphokines characteristic of TH1 cells. By contrast, T cell lines established with the aid of IL 4 as growth factor (LNC.4) produced mainly lymphokines representative of TH2 cells. Apart from their pattern of lymphokine secretion LNC.2 and LNC.4 T cells were found to differ in their proliferative response to lymphokines and Con A. LNC.2 T cells proliferated only …

Interleukin 2medicine.medical_specialtyT-Lymphocytesmedicine.medical_treatmentT cellImmunologyEnzyme-Linked Immunosorbent AssayIn Vitro TechniquesBiologyCell LineInterferon-gammaMiceInterleukin 21Internal medicinemedicineAnimalsImmunology and AllergyRNA MessengerInterleukin 4Mice Inbred BALB CInterleukin-6LymphokineInterleukinT lymphocyteBlotting NorthernCulture MediaEndocrinologyCytokinemedicine.anatomical_structureInterleukin-2Interleukin-3Interleukin-4Interleukin-5Cell Divisionmedicine.drugEuropean Journal of Immunology
researchProduct